My NCBISign In
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
Mervi Jumppanen, Sofia Gruvberger-Saal, Päivikki Kauraniemi, Minna Tanner, Pär-Ola Bendahl, Mikael Lundin, Morten Krogh, Pasi Kataja, Åke Borg, Mårten Fernö, Jorma Isola
Breast Cancer Res. 2007; 9(1): R16. Published online 2007 January 31. doi: 10.1186/bcr1649
PMCID:
PMC1851391
Abstract Full Text PDF–615K Supplementary Material

Is Cited by the Following 18 Articles in this Archive:

Laminin 332 Expression in Breast Carcinoma
Soon-Young Kwon, Seoung W. Chae, Sharon P. Wilczynski, Ahmad Arain, Philip M. Carpenter
Appl Immunohistochem Mol Morphol. Author manuscript; available in PMC 2013 March 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2012 March 1; 20(2): 159–164. doi: 10.1097/PAI.0b013e3182329e8f
PMCID:
PMC3302204
Free in PMC on 2013/03/01
Basal Breast Cancer: A Complex and Deadly Molecular Subtype
F Bertucci, P Finetti, D Birnbaum
Curr Mol Med. 2012 January; 12(1): 96–110. Published online 2012 January. doi: 10.2174/156652412798376134
PMCID:
PMC3343384
Abstract Full Text PDF–871K
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
Eleonor Olsson, Gabriella Honeth, Pär-Ola Bendahl, Lao H Saal, Sofia Gruvberger-Saal, Markus Ringnér, Johan Vallon-Christersson, Göran Jönsson, Karolina Holm, Kristina Lövgren, Mårten Fernö, Dorthe Grabau, Åke Borg, Cecilia Hegardt
BMC Cancer. 2011; 11: 418. Published online 2011 September 29. doi: 10.1186/1471-2407-11-418
PMCID:
PMC3196967
Abstract Full Text PDF–1.0M
Triple-Negative Breast Cancer: Clinical and Histological Correlations
Zeinab Elsawaf, Hans-Peter Sinn
Breast Care (Basel) 2011 August; 6(4): 273–278. Published online 2011 August 26. doi: 10.1159/000331643
PMCID:
PMC3225211
Free in PMC on 2012/08/01
The Changing Role of Pathology in Breast Cancer Diagnosis and Treatment
Anthony S.-Y. Leong, Zhengping Zhuang
Pathobiology. 2011 June; 78(2): 99–114. doi: 10.1159/000292644
PMCID:
PMC3128144
Free in PMC on 2012/06/01
Enhanced Anticancer Effect of the Combination of Cisplatin and TRAIL in Triple-Negative Breast Tumor cells
Liping Xu, Shuping Yin, Kaladhar B Reddy
Mol Cancer Ther. Author manuscript; available in PMC 2012 March 1.
Published in final edited form as: Mol Cancer Ther. 2011 March; 10(3): 550–557. Published online 2011 January 20. doi: 10.1158/1535-7163.MCT-10-0571
PMCID:
PMC3053434
Abstract Full Text PDF–1.2M
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal, Barrett H. Childs, Mark Pegram
Breast Cancer Res Treat. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 February; 125(3): 627–636. Published online 2010 December 15. doi: 10.1007/s10549-010-1293-1
PMCID:
PMC3244802
Abstract Full Text PDF–875K Supplementary Material
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje, Fredrik Wärnberg
BMC Cancer. 2010; 10: 653. Published online 2010 November 30. doi: 10.1186/1471-2407-10-653
PMCID:
PMC3001723
Abstract Full Text PDF–257K
Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma
Ja Seung Koo, WooHee Jung
Yonsei Med J. 2011 January 1; 52(1): 89–97. Published online 2010 November 30. doi: 10.3349/ymj.2011.52.1.89
PMCID:
PMC3017713
Abstract Full Text PDF–549K
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows, Kristy E. Driver, Marjanka K. Schmidt, Annegien Broeks, Flora E. van Leeuwen, Jelle Wesseling, Maggie C. Cheang, Karen Gelmon, Torsten O. Nielsen, Carl Blomqvist, Päivi Heikkilä, Tuomas Heikkinen, Heli Nevanlinna, Lars A. Akslen, Louis R. Bégin, William D. Foulkes, Fergus J. Couch, Xianshu Wang, Vicky Cafourek, Janet E. Olson, Laura Baglietto, Graham G. Giles, Gianluca Severi, Catriona A. McLean, Melissa C. Southey, Emad Rakha, Andrew R. Green, Ian O. Ellis, Mark E. Sherman, Jolanta Lissowska, William F. Anderson, Angela Cox, Simon S. Cross, Malcolm W. R. Reed, Elena Provenzano, Sarah-Jane Dawson, Alison M. Dunning, Manjeet Humphreys, Douglas F. Easton, Montserrat García-Closas, Carlos Caldas, Paul D. Pharoah, David Huntsman
PLoS Med. 2010 May; 7(5): e1000279. Published online 2010 May 25. doi: 10.1371/journal.pmed.1000279
PMCID:
PMC2876119
Abstract Full Text PDF–485K Supplementary Material
Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry
Radzislaw Kordek, Piotr Potemski, Renata Kusinska, Elzbieta Pluciennik, Andrzej Bednarek
J Exp Clin Cancer Res. 2010; 29(1): 39. Published online 2010 April 28. doi: 10.1186/1756-9966-29-39
PMCID:
PMC2873424
Abstract Full Text PDF–548K
Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis
R Fernández-Ramires, X Solé, L De Cecco, G Llort, A Cazorla, N Bonifaci, M J Garcia, T Caldés, I Blanco, M Gariboldi, M A Pierotti, M A Pujana, J Benítez, A Osorio
Br J Cancer. 2009 October 20; 101(8): 1469–1480. Published online 2009 October 13. doi: 10.1038/sj.bjc.6605275
PMCID:
PMC2768459
Abstract Full Text PDF–1.4M Supplementary Material
Does vimentin help to delineate the so-called 'basal type breast cancer'?
Renata U Kusinska, Radzislaw Kordek, Elzbieta Pluciennik, Andrzej K Bednarek, Janusz H Piekarski, Piotr Potemski
J Exp Clin Cancer Res. 2009; 28(1): 118. Published online 2009 August 20. doi: 10.1186/1756-9966-28-118
PMCID:
PMC2738661
Abstract Full Text PDF–1.0M
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
Andrew E Teschendorff, Carlos Caldas
Breast Cancer Res. 2008; 10(4): R73. Published online 2008 August 28. doi: 10.1186/bcr2138
PMCID:
PMC2575547
Abstract Full Text PDF–640K
The CD44+/CD24- phenotype is enriched in basal-like breast tumors
Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg, Cecilia Hegardt
Breast Cancer Res. 2008; 10(3): R53. Published online 2008 June 17. doi: 10.1186/bcr2108
PMCID:
PMC2481503
Abstract Full Text PDF–502K
Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
Hannaleena Eerola, Mira Heinonen, Päivi Heikkilä, Outi Kilpivaara, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Ari Ristimäki, Heli Nevanlinna
Breast Cancer Res. 2008; 10(1): R17. Published online 2008 February 14. doi: 10.1186/bcr1863
PMCID:
PMC2374973
Abstract Full Text PDF–141K
Are triple-negative tumours and basal-like breast cancer synonymous?
Emad A Rakha, David SP Tan, William D Foulkes, Ian O Ellis, Andrew Tutt, Torsten O Nielsen, Jorge S Reis-Filho
Breast Cancer Res. 2007; 9(6): 404. Published online 2007 November 30. doi: 10.1186/bcr1827
PMCID:
PMC2246182
Full Text PDF–42K
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E Teschendorff, Ahmad Miremadi, Sarah E Pinder, Ian O Ellis, Carlos Caldas
Genome Biol. 2007; 8(8): R157. Published online 2007 August 2. doi: 10.1186/gb-2007-8-8-r157
PMCID:
PMC2374988
Abstract Full Text PDF–1.4M Supplementary Material
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk